Navigation Links
Heart damage improves, reverses after stem cell injections in a preliminary human trial
Date:3/17/2011

he researchers had used two different types of bone marrow stem cells in their study mononuclear or mesenchymal stem cells. The study lacked the power to determine if one type of cell works better than the other. All patients in the study benefited from the therapy and tolerated the injections with no serious adverse events.

Hare's study assessed the effect of stem cell injections differently from other studies of post-heart attack stem cell treatment. His team measured contractility, scar size and structural changes of the heart.

"Studies of bone marrow cell therapy for ischemic heart disease in animals have shown improved ejection fraction (the amount of blood the heart can pump). However, this measurement has not reliably translated to early phase studies in humans," Hare said. "Ejection fraction may not be the best way to measure the success of stem cell therapy in the human heart."

Hare also said their findings suggest that patients' quality of life could improve as the result of this therapy because the heart is a more normal size and is better functioning. "But, we have yet to prove this clinical benefit this is an experimental therapy in phase one studies. These findings support further clinical trials and give us hope that we can help people with enlarged hearts."


'/>"/>

Contact: Maggie Francis
maggie.francis@heart.org
214-706-1382
American Heart Association
Source:Eurekalert

Page: 1 2

Related medicine news :

1. In pilot study, screening detects potentially serious heart conditions in healthy children
2. Study Questions Tests Used to Spot Heart Risks in Kidney Patients
3. The 5 hospital factors that affect heart attack survival
4. Inflammation behind heart valve disease
5. Updates Urged for Kids Heart, Breathing Rate Guidelines
6. In Men, Duration of Diabetes Linked to Raised Heart Risk
7. Fat Alone, Not Where It Sits, May Be Key to Heart Problems
8. Hospitals Urged to Check for Depression Before Discharging Heart Patients
9. Government of Canada and Heart and Stroke Foundation take action on obesity
10. Irregular Heart Beat Plus Stroke May Increase Dementia Risk
11. Scientists Link 13 New Gene Regions to Heart Disease Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... Kognito ... and assess their competencies in managing challenging conversations, announced today that Glenn Albright, ... Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury (DCoE) Summit ...
(Date:8/31/2015)... ... August 31, 2015 , ... The Foundation for ... the facts about the role of heredity in below-the-belt gynecologic cancers. , ... Angelina Jolie Pitt’s decisions to have both her breasts and ovaries removed to ...
(Date:8/31/2015)... ... , ... “My mother and husband use oxygen therapy and the tubing irritates ... could be a comfortable way to prevent the irritation, so I invented this.” She ... more secure way to anchor the cannula tubing used in oxygen therapy and it ...
(Date:8/31/2015)... , ... August 31, 2015 , ... For 12 years, ... have acknowledged September 26th as Mesothelioma Awareness Day . On this day, and ... with several ways of becoming involved and helping the cause. , “One of the ...
(Date:8/31/2015)... ... August 31, 2015 , ... Westchester Insurance, ... Prairie, is teaming up with the Tarrant County chapter of Meals on Wheels ... Wheels is the oldest and largest national organization that supports the more than ...
Breaking Medicine News(10 mins):Health News:Kognito’s Glenn Albright to Present at DCoE Summit 2Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 2Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 3Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 4Health News:InventHelp® Inventor Designs Nasal Cannula Ear Protector (AVZ-1217) 2Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 2Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 3Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 2Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 3
... double by waiting even a day after discharge, study finds ... people who have stents implanted to keep an artery open ... Plavix immediately, and that ignorance nearly doubles their risk for ... study, which involved 7,402 people who had the thin tubes ...
... processed foods account for nearly 16% of daily intake, ... The added sugars in prepared and processed foods are ... cholesterol, raising levels of potentially dangerous triglcerides and possibly ... looked at a group of people representative of the ...
... D.C. Levels of epidermal growth factor receptor (EGFR) may ... prior to their breast cancer diagnosis, according to findings presented ... 2010, held here April 17-21. The goal of the ... of the Epidemiology Program at the Fred Hutchinson Cancer Research ...
... that when a thin person is seen laying down ... see an overweight person relaxing, it,s automatically assumed they,re ... of A,s Faculty of Physical Education and Recreation, says ... Berry says just because a person is overweight, it ...
... ... Administration (FDA) approved an Investigational New Drug (IND) for a clinical trial for ischemic ... ... April 20, 2010 -- Stemedica Cell Technologies, Inc. (Stemedica), a world leader ...
... computer games helped in any way , TUESDAY, April ... reports that popular brain-training computer games do not improve ... conducted by the Medical Research Council (MRC) in collaboration ... these brain games do little to boost the ability ...
Cached Medicine News:Health News:Many Don't Take Blood Thinner After Getting Stents 2Health News:Many Don't Take Blood Thinner After Getting Stents 3Health News:Added Sugars in Diet Threaten Heart Health 2Health News:Added Sugars in Diet Threaten Heart Health 3Health News:Increased EGFR levels may be an early marker of breast cancer 2Health News:FDA Approves Stemedica IND for Ischemic Stroke Clinical Trial 2Health News:'Brain Games' Do Not Make You Smarter 2Health News:'Brain Games' Do Not Make You Smarter 3
(Date:8/31/2015)... , August 31, 2015 ... BOLT, OTCQX: BLGTY) ("BioLight" or the "Company"), a ... innovations in ophthalmology and cancer diagnostics, today announced ... MCTC), has identified several new genetic markers with ... in patients treated with bisphosphonate drugs and was ...
(Date:8/31/2015)... PARK, Calif. , Aug. 31, 2015 /PRNewswire/ ... company focused on the emerging field of regenerative ... successfully dosed at Chicago -based ... clinical trial evaluating activity of escalating doses of ... with sensory and motor complete cervical spinal cord ...
(Date:8/31/2015)... , Aug. 31, 2015 Bionomics Limited ... and development of innovative therapeutics for the treatment of ... today announced that its BNC101 IND submission has passed ... Bionomics plans to initiate a Phase 1 clinical trial ... with metastatic pancreatic cancer prior to 31 December 2015. ...
Breaking Medicine Technology:BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4
... Inspiration Biopharmaceuticals, Inc. (Inspiration) today announced data from ... recombinant porcine factor VIII product (rpFVIII), intended for the ... inhibitors and in people with acquired hemophilia.  The data ... with the 23rd Congress of the International Society on ...
... Varian Medical Systems (NYSE: VAR ) has ... to hospitals in Scotland as part of a major nationwide ... accelerators, ancillary equipment and software from Varian, the world leader ... ageing treatment machines at radiotherapy departments in Glasgow, Edinburgh, Dundee, ...
Cached Medicine Technology:Inspiration Biopharmaceuticals Announces Data from OBI-1 Pivotal-Stage Program in Hemophilia at 23rd ISTH Congress 2Inspiration Biopharmaceuticals Announces Data from OBI-1 Pivotal-Stage Program in Hemophilia at 23rd ISTH Congress 3Inspiration Biopharmaceuticals Announces Data from OBI-1 Pivotal-Stage Program in Hemophilia at 23rd ISTH Congress 4Inspiration Biopharmaceuticals Announces Data from OBI-1 Pivotal-Stage Program in Hemophilia at 23rd ISTH Congress 5Scottish Executive Awards Varian Medical Systems Major Contract to Supply Advanced Radiotherapy Equipment to Scotland's Five Cancer Centers 2Scottish Executive Awards Varian Medical Systems Major Contract to Supply Advanced Radiotherapy Equipment to Scotland's Five Cancer Centers 3